long-term effects of glp-1 receptor agonists Medications: What You Should Know Your guide to GLP-1 side
Description
As with other GLP-1 medicines, people with: A history of severe gastrointestinal disease Pancreatitis Significant kidney or liver issues should only use GLP-1 treatments under close clinical monitoring
Long-term gastrointestinal outcomes of COVID-19
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Rev Neurosci (2016) 27(1):6170
Patients with obesity and HFpEF typically have increased pulmonary vascular resistance and mean pulmonary artery pressure, as well as signs of right ventricular dysfunction
Between 2019 and December 2023 there has been a greater than 932% increase in prescriptions for semaglutide medications
